您现在的位置： 首页   -  产品中心   -  免疫学   -   抗体
Anti-PD-L1 Monoclonal Antibody(Atezolizumab)

Anti-PD-L1 Monoclonal Antibody(Atezolizumab)

货号: S0B0555
价格: 1750
规格: 1mg
介绍: -
其他: -
产品规格

  • 宿主来源

    Human

  • 抗原名称

    PD-L1

  • 分子别名

    Programmed cell death 1 ligand 1, PDCD1 ligand 1, Programmed death ligand 1, hPD-L1, B7 homolog 1, B7-H1, CD274, B7H1, PDCD1L1, PDCD1LG1

  • Accession

    Q9NZQ7

  • 克隆号

    S-SC015

  • 抗体类型

    Recombinant mAb

  • 抗体同种型

    IgG1,k

  • 应用

    Blocking of PD-1/PD-L1 signaling Functional assays

  • 纯化方式

    Protein A

  • 浓度

    2 mg/ml

  • 内毒素含量

    <1EU/mg

  • 标记

    Unconjugated

  • 性状

    Liquid

  • 缓冲体系

    PBS pH7.4, containing no preservative

  • 储存条件

    12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

稀释度
应用 稀释度
ELISA 1.221-5000 ng/ml
背景介绍

  • Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), hepatocellular carcinoma and alveolar soft part sarcoma. It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1).

  • ELISA

    • Immobilized human PD-L1 at 0.5 μg/ml (50 μL/well) can bind to Atezolizumab with a linear range of 1.221 ng/ml-5 μg/ml.